• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Owlet Commits Critical Support To Parents and Researchers On A Mission To End SIDS

    10/2/23 8:30:00 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials
    Get the next $OWLT alert in real time by email

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart baby monitoring, is on a mission to raise critical funds for research that could bring an end to sudden infant death syndrome (SIDS). Owlet is partnering in this effort with Dr. Carmel Harrington, Honorary Research Fellow at Sydney Children's Hospital Westmead, and Elisha Palmer of Knox Blocks Foundation, both of whom are parents that have lost a child to SIDS.

    Sudden unexpected infant death (SUID), which includes SIDS, claims the lives of more than 3,000 babies each year in the U.S. alone1. The rate of SIDS is on the rise in the U.S.2 – making it one of the leading causes of infant mortality3. Despite this, there is minimal education, funding, and attention for this global health crisis.

    Dr. Harrington, who lost her son to SIDS more than 30 years ago, made a significant breakthrough last year by identifying a potential biomarker in babies who passed away from SIDS. The next phase of her team's work is to identify the array of biomarkers that can determine which babies are at a higher risk of SIDS, with the end goal of developing and providing access to preventative screenings for every baby.

    "As a doctor and a mom who lost a baby to SIDS more than 30 years ago, it's infuriating that the rate of babies dying from this has not changed in almost three decades, yet the funding available for research into why this happens pales in comparison to other areas of research funding," said Dr. Harrington. "Last year, we made immense progress in the field of SIDS research, but we did not find a cause. It's crucial that my team and I continue to build on the findings we have to find a clear cause, and in the near future, significantly reduce the number of babies who die every day due to SIDS."

    In honor of SIDS Awareness Month, Knox Blocks Foundation, along with other nonprofit partners, have launched a GoFundMe campaign to directly support Dr. Harrington's research with the objective of raising $150,000 by the end of October to finish the next leg of her research and help specifically pinpoint infants at risk of SIDS.

    "After I met with Dr. Harrington for the first time I walked away with a feeling I hadn't had since my son died – and that is hope," said Elisha Palmer, Co-Founder of Knox Blocks Foundation. "Hope is something that easily gets lost when your life is impacted by SIDS, and that's when I knew we had to help in any way we could. By raising $150,000 to continue Dr. Harrington's research, other families around the world might not have to go through the pain that our family and countless others experience when they lose a baby to SIDS."

    During the month of October, Owlet is donating 5% of all sales made globally on OwletCare.com to this project in support of Dr. Harrington's research. Along with providing direct funding, Owlet supports parents of loss through various Owlet Cares initiatives. These programs include Owlet's Nursery of Hope nationwide initiative to plant trees in honor of babies who are gone but never forgotten, partnerships with and 3:1 product match program for nonprofit organizations, and charitable support including our most recent milestone of donating $1M in product and monetary donations to advancing infant and maternal health.

    "Owlet believes that no baby should die unexpectedly in their sleep and we are determined to raise awareness and advocate for more research in this area," said Kurt Workman, Owlet CEO and Co-Founder. "This and every month, we invite parents and caregivers to join us and participate in a historical movement to end SIDS. We will not stop fighting for change until every new parent has the knowledge, tools, and education they need to avoid a loss due to SIDS."

    To contribute directly to Dr. Harrington's SIDS research, go to www.gofundme.com/f/a-world-without-sids-make-an-impact-today. To learn more about Owlet's mission and to find other ways to get involved, please visit www.owletcare.com/sids-awareness.

    About Owlet, Inc.

    Owlet was founded by a team of parents in 2012. Owlet's mission is to empower parents with the right information at the right time, to give them more peace of mind and help them find more joy in the journey of parenting. Owlet's digital parenting platform aims to give parents real-time data and insights to help parents feel calmer and more confident. Owlet believes that every parent deserves peace of mind and the opportunity to feel their well-rested best. Owlet also believes that every child deserves to live a long, happy, and healthy life, and is working to develop products to help further that belief. To learn more, visit www.owletcare.com.

    About Dr. Carmel Harrington

    Dr. Harrington, a former lawyer, originally trained as a biochemist. Her son, Damien, passed away from SIDS more than 30 years ago, and Dr. Harrington has since committed her life to trying to find the cause of his death. In 2022, she found that 88% of babies who died of SIDS had a lower level of an enzyme connected with autonomic function. Her study was the first to identify a biomarker in SIDS infants prior to their death and presents a possibility that with further research, infants at risk of SIDS could be identified in their newborn period. She is currently planning her future studies which will include proteomic and metabolomic investigations – with her ultimate aim being the development of a test that will effectively detect an infant's vulnerability to SIDS and integration into newborn screening programs.

    About Knox Blocks Foundation

    Knox Blocks Foundation, a 501(C)(3) nonprofit organization, was founded by Mark and Elisha Palmer after their son, Knox Owen Palmer, passed away from SIDS. After losing their son, Mark and Elisha wanted to do everything they could to prevent other families from feeling the pain they experienced from their loss. Their desire to do this led them to create the Knox Blocks Foundation, a nonprofit dedicated to providing Owlet Socks to as many infants as possible and supporting SIDS research. To learn more, visit www.knoxblocks.org.

    References:

    1: https://www.cdc.gov/sids/data.htm

    2: https://publications.aap.org/pediatrics/article/151/4/e2022058820/190834/Sudden-Unexpected-Infant-Deaths-2015-2020?autologincheck=redirected

    3: https://www.cdc.gov/reproductivehealth/maternalinfanthealth/infantmortality.htm

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20231002612208/en/

    Get the next $OWLT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OWLT

    DatePrice TargetRatingAnalyst
    4/23/2025$7.00Outperform
    Northland Capital
    10/6/2021$12.00 → $5.00Neutral
    Citigroup
    10/5/2021$8.50 → $5.50Buy → Neutral
    BofA Securities
    9/8/2021$8.50Buy
    BofA Securities
    8/5/2021$11.00Neutral
    Citigroup
    More analyst ratings

    $OWLT
    SEC Filings

    View All

    Amendment: Owlet Inc. filed SEC Form 8-K: Financial Statements and Exhibits, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities

    8-K/A - Owlet, Inc. (0001816708) (Filer)

    8/13/25 4:45:01 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    SEC Form 10-Q filed by Owlet Inc.

    10-Q - Owlet, Inc. (0001816708) (Filer)

    8/8/25 4:25:13 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    SEC Form DEFA14A filed by Owlet Inc.

    DEFA14A - Owlet, Inc. (0001816708) (Filer)

    8/7/25 5:01:17 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Owlet® Achieves TGA Certification for Dream Sock™, Paving the Way for Launch in Australia and New Zealand

    Certification underscores Owlet's commitment to bringing medically-certified infant monitoring technology to every family across the globe. Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announces that Dream Sock™ has received official certification from Australia's Therapeutic Goods Administration (TGA), meeting rigorous standards required for medical devices in the region. "TGA certification of Dream Sock marks an important step forward in our global expansion, bringing more families worldwide access to the latest pediatric health monitoring technology," said Jonathan Harris, Owlet's President. "For parents in these markets, certifica

    8/21/25 8:45:00 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet Reports Second Quarter 2025 Financial Results; Increases Full Year 2025 Guidance; Announces CEO Transition Plan

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the second quarter ended June 30, 2025. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business and corporate update today, August 7, 2025, at 4:30 p.m. ET. Q2 2025 Financial Highlights Q2 Revenue of $26.1 million, up 25.9% from Q2 2024 Q2 Gross Margin of 51.3%, up 180 basis points from Q2 2024 Q2 Net Loss of $37.6 million, including a $34.8 million non-cash, mark-to-market common stock w

    8/7/25 4:05:00 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet to Simplify Capital Structure Through Exchange of Series A and Series B Warrants for Common Stock

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today announced an agreement with a majority of the holders of the Company's Series A and Series B warrants to exchange their warrants for common stock. "We're very pleased to simplify our capital structure through today's announced warrant exchange," said Jonathan Harris, Owlet's President. "The successful exchange of these warrants will be an important milestone that we believe improves the attractiveness of our stock, strengthens our capital structure, and supports the long-term success of the business." As a part of the exchange, the Company will issue an aggregate of 5,426,429 shares of comm

    8/7/25 4:01:00 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Northland Capital initiated coverage on Owlet with a new price target

    Northland Capital initiated coverage of Owlet with a rating of Outperform and set a new price target of $7.00

    4/23/25 9:11:45 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Citigroup reiterated coverage on Owlet with a new price target

    Citigroup reiterated coverage of Owlet with a rating of Neutral and set a new price target of $5.00 from $12.00 previously

    10/6/21 12:45:24 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet downgraded by BofA Securities with a new price target

    BofA Securities downgraded Owlet from Buy to Neutral and set a new price target of $5.50 from $8.50 previously

    10/5/21 7:41:47 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President Harris Jonathan sold $56,606 worth of shares (14,170 units at $3.99), decreasing direct ownership by 5% to 266,707 units (SEC Form 4)

    4 - Owlet, Inc. (0001816708) (Issuer)

    5/21/25 9:15:54 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Chief Financial Officer Crawford Amanda sold $783 worth of shares (182 units at $4.30), decreasing direct ownership by 0.12% to 150,508 units (SEC Form 4)

    4 - Owlet, Inc. (0001816708) (Issuer)

    1/21/25 9:30:13 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    President & CRO Harris Jonathan sold $106,436 worth of shares (24,179 units at $4.40), decreasing direct ownership by 8% to 280,877 units (SEC Form 4)

    4 - Owlet, Inc. (0001816708) (Issuer)

    1/21/25 9:24:43 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    Financials

    Live finance-specific insights

    View All

    Owlet Reports Second Quarter 2025 Financial Results; Increases Full Year 2025 Guidance; Announces CEO Transition Plan

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the second quarter ended June 30, 2025. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business and corporate update today, August 7, 2025, at 4:30 p.m. ET. Q2 2025 Financial Highlights Q2 Revenue of $26.1 million, up 25.9% from Q2 2024 Q2 Gross Margin of 51.3%, up 180 basis points from Q2 2024 Q2 Net Loss of $37.6 million, including a $34.8 million non-cash, mark-to-market common stock w

    8/7/25 4:05:00 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet to Report Second Quarter 2025 Financial Results on August 7, 2025

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT) plans to announce second quarter 2025 financial results after market close on Thursday, August 7, 2025. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the call at 833-470-1428 (domestic) or 404-975-4839 (international) and reference Access Code 579904. A simultaneous webcast may be accessed online at the Events section of Owlet's Investor Relations website at investors.owletcare.com. A replay will be available

    7/24/25 4:05:00 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet Announces First Quarter 2025 Financial Results

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), the pioneer of smart infant monitoring, today reports financial results for the first quarter ended March 31, 2025. Owlet's Chief Executive Officer and Co-Founder, Kurt Workman; President, Jonathan Harris; and Chief Financial Officer, Amanda Twede Crawford, will host a conference call to review the Company's results and provide a business update today, May 8, 2025, at 4:30 p.m. ET. Q1 2025 Financial Highlights: Q1 Revenue of $21.1 million, up 43.1% from Q1 2024 Q1 Gross Margin of 53.7%, up 930 basis points from Q1 2024 Q1 Net Income of $3.0 million, compared to $3.3 million in Q1 2024 Q1 Adjusted EBITDA of $0.0 million, improving

    5/8/25 4:05:00 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    Leadership Updates

    Live Leadership Updates

    View All

    Owlet Commits Critical Support To Parents and Researchers On A Mission To End SIDS

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart baby monitoring, is on a mission to raise critical funds for research that could bring an end to sudden infant death syndrome (SIDS). Owlet is partnering in this effort with Dr. Carmel Harrington, Honorary Research Fellow at Sydney Children's Hospital Westmead, and Elisha Palmer of Knox Blocks Foundation, both of whom are parents that have lost a child to SIDS. Sudden unexpected infant death (SUID), which includes SIDS, claims the lives of more than 3,000 babies each year in the U.S. alone1. The rate of SIDS is on the rise in the U.S.2 – making it one of the leading causes of infant mortality3. Despite this, there is m

    10/2/23 8:30:00 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet Appoints Eclipse Partner Marc Stoll to Board of Directors

    Owlet, Inc. ("Owlet" or the "Company") (NYSE:OWLT), a pioneer of smart baby monitoring, today announces the appointment of Marc Stoll to the Company's Board of Directors. Stoll is currently an Investment Partner at Eclipse, a strategic investment firm focused on advancing the Industrial Evolution. His experience spans more than 25 years across the global finance and technology industries, and his expertise in leading corporate strategy and operational excellence will help bolster Owlet's future ventures and growth potential. "I'm thrilled to join Owlet's Board of Directors after spending time becoming very familiar with the brand and products, its life-changing mission and amazing custome

    8/16/23 9:00:00 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Owlet Appoints Healthcare Executive Melissa Gonzales to Board of Directors

    Owlet, Inc. (NYSE:OWLT, "the Company"))), the pioneer of smart baby monitoring, is pleased to announce the addition of Melissa Gonzales to the Company's Board of Directors. Gonzales brings more than 20 years of consumer and provider healthcare experience to Owlet, further advancing the Company as a leader in infant monitoring solutions. "Owlet's growth proposition to facilitate change in health equity through its innovation in connected digital monitoring is extremely exciting," said Melissa Gonzales. "Creating meaningful momentum and impact within these trends is important to me personally and professionally and I am looking forward to contributing my experience towards supporting Owlet'

    7/19/23 9:00:00 AM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    $OWLT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Owlet Inc.

    SC 13G/A - Owlet, Inc. (0001816708) (Subject)

    10/24/24 4:05:58 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13D/A filed by Owlet Inc.

    SC 13D/A - Owlet, Inc. (0001816708) (Subject)

    8/22/24 6:39:55 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13D/A filed by Owlet Inc.

    SC 13D/A - Owlet, Inc. (0001816708) (Subject)

    8/22/24 4:25:26 PM ET
    $OWLT
    Industrial Machinery/Components
    Industrials